Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 376

1.

Evaluation of folic acid supplementation by concomitant administration of ethinyl estradiol + levonorgestrel in healthy female subjects
.

de Moraes Jacob J, de Jesus Antunes N, Moreno R, De Nucci G.

Int J Clin Pharmacol Ther. 2019 Jun;57(6):290-297. doi: 10.5414/CP203293.

PMID:
30900980
2.

Short article: Hormone therapy for severe gastrointestinal bleeding due to multiple angiodysplastic lesions.

Torrente Iranzo S, Sarasqueta Eizaguirre C, Gonzalez Canalizo V, Segues Merino NM, Ortega Rezola P, Wong Arteta J, Medina Del Valle A, Cosme Jimenez Á, Bujanda L.

Eur J Gastroenterol Hepatol. 2019 Mar;31(3):312-315. doi: 10.1097/MEG.0000000000001139.

PMID:
30676471
3.

Ethinylestradiol and Levonorgestrel as Active Agents in Normal Skin, and Pathological Conditions Induced by UVB Exposure: In Vitro and In Ovo Assessments.

Coricovac D, Farcas C, Nica C, Pinzaru I, Simu S, Stoian D, Soica C, Proks M, Avram S, Navolan D, Dumitru C, Popovici RA, Dehelean CA.

Int J Mol Sci. 2018 Nov 14;19(11). pii: E3600. doi: 10.3390/ijms19113600.

4.

The effect of laquinimod, a novel immuno-modulator in development to treat Huntington disease, on the pharmacokinetics of ethinylestradiol and levonorgestrel in healthy young women.

Elgart A, Zur AA, Mimrod D, Dror V, Bar-Ilan O, Korver T, Spiegelstein O.

Eur J Clin Pharmacol. 2019 Jan;75(1):41-49. doi: 10.1007/s00228-018-2549-7. Epub 2018 Sep 6.

PMID:
30191262
5.

Impact of contraceptive initiation on vaginal microbiota.

Achilles SL, Austin MN, Meyn LA, Mhlanga F, Chirenje ZM, Hillier SL.

Am J Obstet Gynecol. 2018 Jun;218(6):622.e1-622.e10. doi: 10.1016/j.ajog.2018.02.017. Epub 2018 Mar 2.

6.

Magnetic resonance imaging and spectroscopy evidence of efficacy for adrenal and gonadal hormone replacement therapy in anorexia nervosa.

Vajapeyam S, Ecklund K, Mulkern RV, Feldman HA, O'Donnell JM, DiVasta AD, Rosen CJ, Gordon CM.

Bone. 2018 May;110:335-342. doi: 10.1016/j.bone.2018.02.021. Epub 2018 Feb 26.

7.

Norethindrone acetate versus extended-cycle oral contraceptive (Seasonique®) in the treatment of endometriosis symptoms: A prospective open-label comparative study.

Scala C, Leone Roberti Maggiore U, Barra F, Venturini PL, Ferrero S.

Eur J Obstet Gynecol Reprod Biol. 2018 Mar;222:89-94. doi: 10.1016/j.ejogrb.2018.01.022. Epub 2018 Feb 3.

PMID:
29408753
8.

Oral hormonal therapy with ethinylestradiol-levonorgestrel improves insulin resistance, obesity, and glycogen synthase kinase-3 independent of circulating mineralocorticoid in estrogen-deficient rats.

Adeyanju OA, Soetan OA, Soladoye AO, Olatunji LA.

Can J Physiol Pharmacol. 2018 Jun;96(6):577-586. doi: 10.1139/cjpp-2017-0630. Epub 2018 Feb 3.

PMID:
29400073
9.

Is Shifting to a Progestin Worthwhile When Estrogen-Progestins Are Inefficacious for Endometriosis-Associated Pain?

Vercellini P, Ottolini F, Frattaruolo MP, Buggio L, Roberto A, Somigliana E.

Reprod Sci. 2018 May;25(5):674-682. doi: 10.1177/1933719117749759. Epub 2018 Jan 5.

10.

Effects of Flibanserin on the Pharmacokinetics of a Combined Ethinylestradiol/Levonorgestrel Oral Contraceptive in Healthy Premenopausal Women: A Randomized Crossover Study.

Johnson-Agbakwu C, Brown L, Yuan J, Kissling R, Greenblatt DJ.

Clin Ther. 2018 Jan;40(1):64-73. doi: 10.1016/j.clinthera.2017.08.021. Epub 2017 Dec 2.

11.

Hypercupremia secondary to oral contraceptives: report of 2 cases.

Araujo Castro M, Prieto Coca L, Izquierdo Álvarez C, Oliván Palacios B, Campos Del Portillo R.

Endocrinol Diabetes Nutr. 2017 Nov;64(9):509-511. doi: 10.1016/j.endinu.2017.08.002. Epub 2017 Sep 18. English, Spanish. No abstract available.

PMID:
29050708
12.
13.

Phototoxic reaction to a combined oral contraceptive (levonorgestrel/ethinylestradiol).

Richarz NA, Aguilera J, Castillo G, Fuente MJ, Ferrándiz C, Carrascosa JM.

Photochem Photobiol Sci. 2017 Sep 13;16(9):1381-1383. doi: 10.1039/c7pp00160f.

PMID:
28825075
14.

Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database.

Hasegawa S, Matsui T, Hane Y, Abe J, Hatahira H, Motooka Y, Sasaoka S, Fukuda A, Naganuma M, Hirade K, Takahashi Y, Kinosada Y, Nakamura M.

PLoS One. 2017 Jul 21;12(7):e0182045. doi: 10.1371/journal.pone.0182045. eCollection 2017.

15.

Normalizing Ovulation Rate by Preferential Reduction of Hepato-Visceral Fat in Adolescent Girls With Polycystic Ovary Syndrome.

Ibáñez L, Del Río L, Díaz M, Sebastiani G, Pozo ÓJ, López-Bermejo A, de Zegher F.

J Adolesc Health. 2017 Oct;61(4):446-453. doi: 10.1016/j.jadohealth.2017.04.010. Epub 2017 Jul 14.

PMID:
28712591
16.

[Efficacy and impact on quality of life of different drug treatments after partial resection of rectovaginal endometriosis].

Li T, Xu XX, Dai Y, Zhang JJ, Lang JH, Leng JH.

Zhonghua Fu Chan Ke Za Zhi. 2017 May 25;52(5):307-313. doi: 10.3760/cma.j.issn.0529-567X.2017.05.004. Chinese.

PMID:
28545268
17.

Anti-inflammatory and antithrombotic effects of nicotine exposure in oral contraceptive-induced insulin resistance are glucocorticoid-independent.

Olatunji LA, Michael OS, Adeyanju OA, Areola ED, Soladoye AO.

Pharmacol Rep. 2017 Jun;69(3):512-519. doi: 10.1016/j.pharep.2016.12.010. Epub 2016 Dec 19.

PMID:
28349880
18.

No clinically meaningful pharmacokinetic interaction between the hepatitis C virus inhibitors elbasvir and grazoprevir and the oral contraceptives ethinyl estradiol and levonorgestrel.

Marshall WL, Feng HP, Caro L, Talaty J, Guo Z, Huang X, Panebianco D, Ma J, Mangin E, O'Reilly TE, Butterton JR, Yeh WW.

Eur J Clin Pharmacol. 2017 May;73(5):593-600. doi: 10.1007/s00228-017-2216-4. Epub 2017 Feb 24.

PMID:
28233047
19.

Endogenous thrombin potential changes during the first cycle of oral contraceptive use.

Westhoff CL, Pike MC, Cremers S, Eisenberger A, Thomassen S, Rosing J.

Contraception. 2017 May;95(5):456-463. doi: 10.1016/j.contraception.2017.01.001. Epub 2017 Jan 11.

20.

Comparison of combined hormonal vaginal ring and low dose combined oral hormonal pill for the treatment of idiopathic chronic pelvic pain: a randomised trial.

Priya K, Rajaram S, Goel N.

Eur J Obstet Gynecol Reprod Biol. 2016 Dec;207:141-146. doi: 10.1016/j.ejogrb.2016.10.026. Epub 2016 Nov 8.

PMID:
27863271

Supplemental Content

Loading ...
Support Center